Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0345904 (
liver cancer
)
15,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Breast cancer is a common malignancy, but the understanding of its cellular and molecular mechanisms is limited.
ZFHX3
, a transcription factor with many homeodomains and zinc fingers, suppresses prostatic carcinogenesis but promotes tumor growth of
liver cancer
cells.
ZFHX3
regulates mammary epithelial cells' proliferation and differentiation by interacting with estrogen and progesterone receptors, potent breast cancer regulators. However, whether
ZFHX3
plays a role in breast carcinogenesis is unknown. Here, we found that
ZFHX3
promoted the proliferation and tumor growth of breast cancer cells in culture and nude mice; and higher expression of
ZFHX3
in human breast cancer specimens was associated with poorer prognosis. The knockdown of
ZFHX3
in
ZFHX3
-high MCF-7 cells decreased, and
ZFHX3
overexpression in
ZFHX3
-low T-47D cells increased the proportion of breast cancer stem cells (BCSCs) defined by mammosphere formation and the expression of CD44, CD24, and/or aldehyde dehydrogenase 1. Among several transcription factors that have been implicated in BCSCs, MYC and TBX3 were transcriptionally activated by
ZFHX3
via promoter binding, as demonstrated by luciferase-reporter and ChIP assays. These findings suggest that
ZFHX3
promotes breast cancer cells' proliferation and tumor growth likely by enhancing BCSC features and upregulating
MYC
,
TBX3
, and others.
...
PMID:ZFHX3 Promotes the Proliferation and Tumor Growth of ER-Positive Breast Cancer Cells Likely by Enhancing Stem-Like Features and
MYC
and
TBX3
Transcription. 3321 82